ID   THYG_HUMAN              Reviewed;        2768 AA.
AC   P01266; O15274; O43899; Q15593; Q15948; Q9NYR1; Q9NYR2; Q9UMZ0;
AC   Q9UNY3;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 5.
DT   22-FEB-2012, entry version 142.
DE   RecName: Full=Thyroglobulin;
DE            Short=Tg;
DE   Flags: Precursor;
GN   Name=TG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ASP-604; ASP-653;
RP   GLN-985 DEL; TYR-1043; THR-1059; GLY-1312; ARG-1437; HIS-1463;
RP   THR-1936; GLU-2091; LEU-2149; ARG-2170 AND HIS-2242.
RX   MEDLINE=87246630; PubMed=3595599;
RX   DOI=10.1111/j.1432-1033.1987.tb11466.x;
RA   Malthiery Y., Lissitzky S.;
RT   "Primary structure of human thyroglobulin deduced from the sequence of
RT   its 8448-base complementary DNA.";
RL   Eur. J. Biochem. 165:491-498(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLY-1312.
RC   TISSUE=Thyroid;
RX   MEDLINE=97329813; PubMed=9186272;
RA   van de Graaf S.A.R., Pauws E., de Vijlder J.J.M., Ris-Stalpers C.;
RT   "The revised 8307 base pair coding sequence of human thyroglobulin
RT   transiently expressed in eukaryotic cells.";
RL   Eur. J. Endocrinol. 136:508-515(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-515.
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-730, AND VARIANTS ASP-604 AND ASP-653.
RX   MEDLINE=85127024; PubMed=3971976;
RX   DOI=10.1111/j.1432-1033.1985.tb08717.x;
RA   Malthiery Y., Lissitzky S.;
RT   "Sequence of the 5'-end quarter of the human-thyroglobulin messenger
RT   ribonucleic acid and of its deduced amino-acid sequence.";
RL   Eur. J. Biochem. 147:53-58(1985).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-415; 640-737 AND 880-1000, AND
RP   VARIANT ALA-734.
RX   MEDLINE=88062712; PubMed=3681978; DOI=10.1016/0022-2836(87)90403-7;
RA   Parma J., Christophe D., Pohl V., Vassart G.;
RT   "Structural organization of the 5' region of the thyroglobulin gene.
RT   Evidence for intron loss and 'exonization' during evolution.";
RL   J. Mol. Biol. 196:769-779(1987).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-25.
RX   MEDLINE=85269632; PubMed=2991855; DOI=10.1093/nar/13.14.5127;
RA   Christophe D., Cabrer B., Bacolla A., Targovnik H.M., Pohl V.,
RA   Vassart G.;
RT   "An unusually long poly(purine)-poly(pyrimidine) sequence is located
RT   upstream from the human thyroglobulin gene.";
RL   Nucleic Acids Res. 13:5127-5144(1985).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1002-1566 (ISOFORM 1), AND
RP   VARIANT GLY-1312.
RX   MEDLINE=21064424; PubMed=11124863; DOI=10.1530/eje.0.1430789;
RA   Moya C.M., Mendive F.M., Rivolta C.M., Vassart G., Targovnik H.M.;
RT   "Genomic organization of the 5' region of the human thyroglobulin
RT   gene.";
RL   Eur. J. Endocrinol. 143:789-798(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1645-2768, AND VARIANTS LEU-2149
RP   AND ARG-2170.
RX   MEDLINE=99452200; PubMed=10524569;
RA   Mendive F.M., Rivolta C.M., Vassart G., Targovnik H.M.;
RT   "Genomic organization of the 3' region of the human thyroglobulin
RT   gene.";
RL   Thyroid 9:903-912(1999).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1504-1602 (ISOFORM 2).
RX   MEDLINE=92347597; PubMed=1639210; DOI=10.1016/0303-7207(92)90087-M;
RA   Targovnik H.M., Cochaux P., Corach D., Vassart G.;
RT   "Identification of a minor Tg mRNA transcript in RNA from normal and
RT   goitrous thyroids.";
RL   Mol. Cell. Endocrinol. 84:R23-R26(1992).
RN   [10]
RP   PARTIAL PROTEIN SEQUENCE.
RX   MEDLINE=89121111; PubMed=2914619; DOI=10.1016/0014-5793(89)80513-7;
RA   Marriq C., Lejeune P.J., Venot N., Vinet L.;
RT   "Hormone synthesis in human thyroglobulin: possible cleavage of the
RT   polypeptide chain at the tyrosine donor site.";
RL   FEBS Lett. 242:414-418(1989).
RN   [11]
RP   PARTIAL PROTEIN SEQUENCE.
RX   MEDLINE=94094855; PubMed=8269951;
RX   DOI=10.1111/j.1432-1033.1993.tb18414.x;
RA   Gentile F., Salvatore G.;
RT   "Preferential sites of proteolytic cleavage of bovine, human and rat
RT   thyroglobulin. The use of limited proteolysis to detect solvent-
RT   exposed regions of the primary structure.";
RL   Eur. J. Biochem. 218:603-621(1993).
RN   [12]
RP   PARTIAL PROTEIN SEQUENCE.
RX   MEDLINE=95314327; PubMed=7793989; DOI=10.1006/abbi.1995.1346;
RA   Xiao S., Pollock H.G., Taurog A., Rawitch A.B.;
RT   "Characterization of hormonogenic sites in an N-terminal, cyanogen
RT   bromide fragment of human thyroglobulin.";
RL   Arch. Biochem. Biophys. 320:96-105(1995).
RN   [13]
RP   PARTIAL PROTEIN SEQUENCE, GLYCOSYLATION AT ASN-76; ASN-198; ASN-484;
RP   ASN-529; ASN-748; ASN-816; ASN-947; ASN-1220; ASN-1348; ASN-1349;
RP   ASN-1365; ASN-1716; ASN-1774; ASN-2013; ASN-2250; ASN-2295 AND
RP   ASN-2582, AND ABSENCE OF GLYCOSYLATION AT ASN-110; ASN-496; ASN-1869
RP   AND ASN-2122.
RX   MEDLINE=96201348; PubMed=8615697; DOI=10.1006/abbi.1996.0093;
RA   Yang S.X., Pollock H.G., Rawitch A.B.;
RT   "Glycosylation in human thyroglobulin: location of the N-linked
RT   oligosaccharide units and comparison with bovine thyroglobulin.";
RL   Arch. Biochem. Biophys. 327:61-70(1996).
RN   [14]
RP   PRESENCE OF A 11TH TYROGLOBULIN TYPE-1 REPEAT.
RX   MEDLINE=96390872; PubMed=8797845;
RX   DOI=10.1111/j.1432-1033.1996.0125h.x;
RA   Molina F., Bouanani M., Pau B., Granier C.;
RT   "Characterization of the type-1 repeat from thyroglobulin, a cysteine-
RT   rich module found in proteins from different families.";
RL   Eur. J. Biochem. 240:125-133(1996).
RN   [15]
RP   IODINATION AT TYR-24; TYR-1310; TYR-2573; TYR-2587 AND TYR-2766.
RX   MEDLINE=89340430; PubMed=2760035;
RA   Lamas L., Anderson P.C., Fox J.W., Dunn J.T.;
RT   "Consensus sequences for early iodination and hormonogenesis in human
RT   thyroglobulin.";
RL   J. Biol. Chem. 264:13541-13545(1989).
RN   [16]
RP   SULFATION.
RX   MEDLINE=99382264; PubMed=10448091; DOI=10.1006/bbrc.1999.1173;
RA   Nlend M.-C., Cauvi D., Venot N., Chabaud O.;
RT   "Sulfated tyrosines of thyroglobulin are involved in thyroid hormone
RT   synthesis.";
RL   Biochem. Biophys. Res. Commun. 262:193-197(1999).
RN   [17]
RP   SULFATION AT TYR-24.
RX   MEDLINE=22275644; PubMed=12387814; DOI=10.1016/S0006-291X(02)02425-7;
RA   Venot N., Nlend M.-C., Cauvi D., Chabaud O.;
RT   "The hormonogenic tyrosine 5 of porcine thyroglobulin is sulfated.";
RL   Biochem. Biophys. Res. Commun. 298:193-197(2002).
RN   [18]
RP   GLYCOSYLATION AT SER-2749.
RX   PubMed=16679516; DOI=10.1074/jbc.M513382200;
RA   Conte M., Arcaro A., D'Angelo D., Gnata A., Mamone G., Ferranti P.,
RA   Formisano S., Gentile F.;
RT   "A single chondroitin 6-sulfate oligosaccharide unit at Ser-2730 of
RT   human thyroglobulin enhances hormone formation and limits proteolytic
RT   accessibility at the carboxyl terminus. Potential insights into
RT   thyroid homeostasis and autoimmunity.";
RL   J. Biol. Chem. 281:22200-22211(2006).
RN   [19]
RP   VARIANT HIS-870.
RX   MEDLINE=93164775; PubMed=8094490; DOI=10.1016/0140-6736(93)90209-Y;
RA   Corral J., Martin C., Perez R., Sanchez I., Mories M.T.,
RA   San Millan J.L., Miralles J.M., Gonzalez-Sarmiento R.;
RT   "Thyroglobulin gene point mutation associated with non-endemic simple
RT   goitre.";
RL   Lancet 341:462-464(1993).
RN   [20]
RP   VARIANTS TDH3 ARG-1264 AND SER-1996, AND VARIANTS HIS-135; ASP-604;
RP   ASP-653; ALA-734; GLU-830; GLN-985 DEL; VAL-1028; TYR-1043; THR-1059;
RP   ARG-1437; HIS-1463; ASN-1838; THR-1936; TRP-1999; GLU-2091; LEU-2149;
RP   ARG-2170; HIS-2242; ARG-2501 AND GLN-2530.
RX   MEDLINE=99213884; PubMed=10199792; DOI=10.1210/jc.84.4.1438;
RA   Hishinuma A., Takamatsu J., Ohyama Y., Yokozawa T., Kanno Y., Kuma K.,
RA   Yoshida S., Matsuura N., Ieiri T.;
RT   "Two novel cysteine substitutions (C1263R and C1995S) of thyroglobulin
RT   cause a defect in intracellular transport of thyroglobulin in patients
RT   with congenital goiter and the variant type of adenomatous goiter.";
RL   J. Clin. Endocrinol. Metab. 84:1438-1444(1999).
RN   [21]
RP   VARIANTS ALA-734; VAL-1028 AND TRP-1979, AND INVOLVEMENT IN AITD3.
RX   PubMed=14657345; DOI=10.1073/pnas.2434175100;
RA   Ban Y., Greenberg D.A., Concepcion E., Skrabanek L., Villanueva R.,
RA   Tomer Y.;
RT   "Amino acid substitutions in the thyroglobulin gene are associated
RT   with susceptibility to human and murine autoimmune thyroid disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:15119-15124(2003).
RN   [22]
RP   VARIANTS TDH3 TYR-1897 AND GLN-2336.
RX   PubMed=16477365; DOI=10.1007/s10038-006-0360-2;
RA   Kitanaka S., Takeda A., Sato U., Miki Y., Hishinuma A., Ieiri T.,
RA   Igarashi T.;
RT   "A novel compound heterozygous mutation in the thyroglobulin gene
RT   resulting in congenital goitrous hypothyroidism with high serum
RT   triiodothyronine levels.";
RL   J. Hum. Genet. 51:379-382(2006).
RN   [23]
RP   VARIANTS TDH3 TYR-183 AND ASP-2234.
RX   PubMed=17532758; DOI=10.1111/j.1365-2265.2007.02889.x;
RA   Caputo M., Rivolta C.M., Esperante S.A., Gruneiro-Papendieck L.,
RA   Chiesa A., Pellizas C.G., Gonzalez-Sarmiento R., Targovnik H.M.;
RT   "Congenital hypothyroidism with goitre caused by new mutations in the
RT   thyroglobulin gene.";
RL   Clin. Endocrinol. (Oxf.) 67:351-357(2007).
RN   [24]
RP   VARIANT TDH3 ARG-2375.
RX   PubMed=17244789; DOI=10.1210/jc.2006-1242;
RA   Kanou Y., Hishinuma A., Tsunekawa K., Seki K., Mizuno Y., Fujisawa H.,
RA   Imai T., Miura Y., Nagasaka T., Yamada C., Ieiri T., Murakami M.,
RA   Murata Y.;
RT   "Thyroglobulin gene mutations producing defective intracellular
RT   transport of thyroglobulin are associated with increased thyroidal
RT   type 2 iodothyronine deiodinase activity.";
RL   J. Clin. Endocrinol. Metab. 92:1451-1457(2007).
RN   [25]
RP   VARIANT TDH3 ASP-2234, AND CHARACTERIZATION OF VARIANT TDH3 ASP-2234.
RX   PubMed=19509106; DOI=10.1210/jc.2009-0150;
RA   Pardo V., Vono-Toniolo J., Rubio I.G., Knobel M., Possato R.F.,
RA   Targovnik H.M., Kopp P., Medeiros-Neto G.;
RT   "The p.A2215D thyroglobulin gene mutation leads to deficient synthesis
RT   and secretion of the mutated protein and congenital hypothyroidism
RT   with wide phenotype variation.";
RL   J. Clin. Endocrinol. Metab. 94:2938-2944(2009).
CC   -!- FUNCTION: Precursor of the iodinated thyroid hormones thyroxine
CC       (T4) and triiodothyronine (T3).
CC   -!- SUBUNIT: Homodimer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Major;
CC         IsoId=P01266-1; Sequence=Displayed;
CC       Name=2; Synonyms=Minor;
CC         IsoId=P01266-2; Sequence=VSP_012655;
CC   -!- TISSUE SPECIFICITY: Thyroid gland specific.
CC   -!- PTM: Sulfated tyrosines are desulfated during iodination.
CC   -!- DISEASE: Defects in TG are the cause of thyroid dyshormonogenesis
CC       3 (TDH3) [MIM:274700]. A disorder due to thyroid
CC       dyshormonogenesis, causing large goiters of elastic and soft
CC       consistency in the majority of patients. Although the degree of
CC       thyroid dysfunction varies considerably among patients with
CC       defective thyroglobulin synthesis, patients usually have a
CC       relatively high serum free triiodothyronine (T3) concentration
CC       with disproportionately low free tetraiodothyronine (T4) level.
CC       The maintenance of relatively high free T3 levels prevents
CC       profound tissue hypothyroidism except in brain and pituitary,
CC       which are dependent on T4 supply, resulting in neurologic and
CC       intellectual defects in some cases.
CC   -!- DISEASE: Variations in TG are associated with susceptibility to
CC       autoimmune thyroid disease type 3 (AITD3) [MIM:608175]. AITDs
CC       including Graves disease (GD) and Hashimoto thyroiditis (HT), are
CC       among the most common human autoimmune diseases. They are complex
CC       diseases, which are caused by an interaction between
CC       susceptibility genes and nongenetic factors, such as infection.
CC   -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family.
CC   -!- SIMILARITY: Contains 11 thyroglobulin type-1 domains.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Thyroglobulin entry;
CC       URL="http://en.wikipedia.org/wiki/Thyroglobulin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X05615; CAA29104.1; -; mRNA.
DR   EMBL; U93033; AAC51924.1; -; mRNA.
DR   EMBL; AF230667; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF235100; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF230666; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF305872; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X02154; CAA26089.1; -; mRNA.
DR   EMBL; X06059; CAA29454.1; -; Genomic_DNA.
DR   EMBL; X06060; CAA29454.1; JOINED; Genomic_DNA.
DR   EMBL; X06061; CAA29454.1; JOINED; Genomic_DNA.
DR   EMBL; X06062; CAA29454.1; JOINED; Genomic_DNA.
DR   EMBL; X06063; CAA29454.1; JOINED; Genomic_DNA.
DR   EMBL; X06064; CAA29454.1; JOINED; Genomic_DNA.
DR   EMBL; X06065; CAA29454.1; JOINED; Genomic_DNA.
DR   EMBL; X06066; CAA29454.1; JOINED; Genomic_DNA.
DR   EMBL; X06067; CAA29455.1; -; Genomic_DNA.
DR   EMBL; X06068; CAA29455.1; JOINED; Genomic_DNA.
DR   EMBL; X06069; CAA29456.1; -; Genomic_DNA.
DR   EMBL; X06070; CAA29456.1; JOINED; Genomic_DNA.
DR   EMBL; X02749; CAA26527.1; -; Genomic_DNA.
DR   EMBL; AF170489; AAD51647.1; -; Genomic_DNA.
DR   EMBL; AF170486; AAD51647.1; JOINED; Genomic_DNA.
DR   EMBL; AF170487; AAD51647.1; JOINED; Genomic_DNA.
DR   EMBL; AF170488; AAD51647.1; JOINED; Genomic_DNA.
DR   EMBL; AF105687; AAC95473.1; -; Genomic_DNA.
DR   EMBL; AF105681; AAC95473.1; JOINED; Genomic_DNA.
DR   EMBL; AF105682; AAC95473.1; JOINED; Genomic_DNA.
DR   EMBL; AF105683; AAC95473.1; JOINED; Genomic_DNA.
DR   EMBL; AF105684; AAC95473.1; JOINED; Genomic_DNA.
DR   EMBL; AF105685; AAC95473.1; JOINED; Genomic_DNA.
DR   EMBL; AF105686; AAC95473.1; JOINED; Genomic_DNA.
DR   EMBL; AF080484; AAD50912.2; -; Genomic_DNA.
DR   EMBL; AF169654; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF169655; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF169656; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF169657; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF169658; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF169659; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF169661; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF169662; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF169663; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF169664; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080472; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080473; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080474; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080475; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080476; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080477; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080478; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080479; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080480; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080481; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080482; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; AF080483; AAD50912.2; JOINED; Genomic_DNA.
DR   EMBL; S40807; AAB22685.1; -; mRNA.
DR   IPI; IPI00306129; -.
DR   IPI; IPI00549199; -.
DR   PIR; A59110; UIHU.
DR   RefSeq; NP_003226.4; NM_003235.4.
DR   UniGene; Hs.654591; -.
DR   ProteinModelPortal; P01266; -.
DR   SMR; P01266; 48-85, 93-161, 314-358, 611-798, 1024-1073, 1147-1211, 2198-2730.
DR   IntAct; P01266; 2.
DR   STRING; P01266; -.
DR   MEROPS; S09.978; -.
DR   PhosphoSite; P01266; -.
DR   DMDM; 126302607; -.
DR   PRIDE; P01266; -.
DR   Ensembl; ENST00000220616; ENSP00000220616; ENSG00000042832.
DR   GeneID; 7038; -.
DR   KEGG; hsa:7038; -.
DR   UCSC; uc003ytw.1; human.
DR   CTD; 7038; -.
DR   GeneCards; GC08P133948; -.
DR   H-InvDB; HIX0034371; -.
DR   HGNC; HGNC:11764; TG.
DR   HPA; CAB000077; -.
DR   HPA; HPA002740; -.
DR   MIM; 188450; gene.
DR   MIM; 274700; phenotype.
DR   MIM; 608175; phenotype.
DR   neXtProt; NX_P01266; -.
DR   PharmGKB; PA36479; -.
DR   eggNOG; COG2272; -.
DR   GeneTree; ENSGT00600000084208; -.
DR   HOVERGEN; HBG017929; -.
DR   InParanoid; P01266; -.
DR   KO; K10809; -.
DR   OMA; RGTFNFS; -.
DR   PhylomeDB; P01266; -.
DR   NextBio; 27497; -.
DR   ArrayExpress; P01266; -.
DR   Bgee; P01266; -.
DR   Genevestigator; P01266; -.
DR   GO; GO:0005615; C:extracellular space; IBA:RefGenome.
DR   GO; GO:0005179; F:hormone activity; IEA:UniProtKB-KW.
DR   GO; GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   GO; GO:0030878; P:thyroid gland development; IEP:UniProtKB.
DR   GO; GO:0006590; P:thyroid hormone generation; IBA:RefGenome.
DR   InterPro; IPR002018; CarbesteraseB.
DR   InterPro; IPR019819; Carboxylesterase_B_CS.
DR   InterPro; IPR016324; Thyroglobulin.
DR   InterPro; IPR000716; Thyroglobulin_1.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   Gene3D; G3DSA:4.10.800.10; Thyroglobulin_1; 13.
DR   Pfam; PF00135; COesterase; 1.
DR   Pfam; PF07699; GCC2_GCC3; 1.
DR   Pfam; PF00086; Thyroglobulin_1; 8.
DR   PIRSF; PIRSF001831; Thyroglobulin; 1.
DR   SMART; SM00211; TY; 10.
DR   SUPFAM; SSF57610; Thyroglobulin_1; 11.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
DR   PROSITE; PS00484; THYROGLOBULIN_1_1; 9.
DR   PROSITE; PS51162; THYROGLOBULIN_1_2; 11.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Congenital hypothyroidism;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Hormone; Iodination; Polymorphism; Reference proteome;
KW   Repeat; Secreted; Signal; Sulfation; Thyroid hormone;
KW   Thyroid hormones biosynthesis.
FT   SIGNAL        1     19
FT   CHAIN        20   2768       Thyroglobulin.
FT                                /FTId=PRO_0000008636.
FT   DOMAIN       31     92       Thyroglobulin type-1 1.
FT   DOMAIN       93    160       Thyroglobulin type-1 2.
FT   DOMAIN      161    297       Thyroglobulin type-1 3.
FT   DOMAIN      298    358       Thyroglobulin type-1 4.
FT   DOMAIN      605    658       Thyroglobulin type-1 5.
FT   DOMAIN      659    726       Thyroglobulin type-1 6.
FT   DOMAIN      727    921       Thyroglobulin type-1 7.
FT   DOMAIN      922   1073       Thyroglobulin type-1 8.
FT   DOMAIN     1074   1145       Thyroglobulin type-1 9.
FT   DOMAIN     1146   1210       Thyroglobulin type-1 10.
FT   REPEAT     1456   1469       Type II.
FT   REPEAT     1470   1486       Type II.
FT   REPEAT     1487   1503       Type II.
FT   DOMAIN     1511   1565       Thyroglobulin type-1 11.
FT   REPEAT     1603   1723       Type IIIA.
FT   REPEAT     1724   1892       Type IIIB.
FT   REPEAT     1893   1995       Type IIIA.
FT   REPEAT     1996   2129       Type IIIB.
FT   REPEAT     2130   2187       Type IIIA.
FT   SITE        110    110       Not glycosylated.
FT   SITE        496    496       Not glycosylated.
FT   SITE       1869   1869       Not glycosylated.
FT   SITE       2122   2122       Not glycosylated.
FT   MOD_RES      24     24       Sulfotyrosine; alternate (By similarity).
FT   MOD_RES      24     24       Thyroxine; alternate.
FT   MOD_RES    1310   1310       Thyroxine.
FT   MOD_RES    2573   2573       Thyroxine.
FT   MOD_RES    2587   2587       Thyroxine.
FT   MOD_RES    2766   2766       Triiodothyronine.
FT   CARBOHYD     76     76       N-linked (GlcNAc...).
FT   CARBOHYD    198    198       N-linked (GlcNAc...).
FT   CARBOHYD    484    484       N-linked (GlcNAc...).
FT   CARBOHYD    529    529       N-linked (GlcNAc...).
FT   CARBOHYD    748    748       N-linked (GlcNAc...).
FT   CARBOHYD    816    816       N-linked (GlcNAc...).
FT   CARBOHYD    947    947       N-linked (GlcNAc...).
FT   CARBOHYD   1220   1220       N-linked (GlcNAc...).
FT   CARBOHYD   1348   1348       N-linked (GlcNAc...) (Probable).
FT   CARBOHYD   1349   1349       N-linked (GlcNAc...).
FT   CARBOHYD   1365   1365       N-linked (GlcNAc...).
FT   CARBOHYD   1716   1716       N-linked (GlcNAc...).
FT   CARBOHYD   1774   1774       N-linked (GlcNAc...).
FT   CARBOHYD   2013   2013       N-linked (GlcNAc...).
FT   CARBOHYD   2250   2250       N-linked (GlcNAc...).
FT   CARBOHYD   2295   2295       N-linked (GlcNAc...).
FT   CARBOHYD   2582   2582       N-linked (GlcNAc...).
FT   CARBOHYD   2749   2749       O-linked (Xyl...) (chondroitin sulfate).
FT   DISULFID     34     52       By similarity.
FT   DISULFID     63     70       By similarity.
FT   DISULFID     72     92       By similarity.
FT   DISULFID     96    120       By similarity.
FT   DISULFID    131    138       By similarity.
FT   DISULFID    140    160       By similarity.
FT   DISULFID    164    183       By similarity.
FT   DISULFID    194    235       By similarity.
FT   DISULFID    301    319       By similarity.
FT   DISULFID    330    336       By similarity.
FT   DISULFID    338    358       By similarity.
FT   DISULFID    608    620       By similarity.
FT   DISULFID    631    636       By similarity.
FT   DISULFID    638    658       By similarity.
FT   DISULFID    662    687       By similarity.
FT   DISULFID    698    703       By similarity.
FT   DISULFID    705    726       By similarity.
FT   DISULFID    730    763       By similarity.
FT   DISULFID    774    898       By similarity.
FT   DISULFID    900    921       By similarity.
FT   DISULFID   1042   1049       By similarity.
FT   DISULFID   1051   1073       By similarity.
FT   DISULFID   1077   1108       By similarity.
FT   DISULFID   1126   1145       By similarity.
FT   DISULFID   1149   1169       By similarity.
FT   DISULFID   1181   1188       By similarity.
FT   DISULFID   1190   1210       By similarity.
FT   DISULFID   1514   1523       By similarity.
FT   DISULFID   1543   1565       By similarity.
FT   DISULFID   2264   2281       Potential.
FT   VAR_SEQ    1510   1567       CVTDCQRNEAGLQCDQNGQYRASQKDRGSGKAFCVDGEGRR
FT                                LPWWETEAPLEDSQCLM -> L (in isoform 2).
FT                                /FTId=VSP_012655.
FT   VARIANT     135    135       Q -> H (in dbSNP:rs2069546).
FT                                /FTId=VAR_010212.
FT   VARIANT     183    183       C -> Y (in TDH3).
FT                                /FTId=VAR_063034.
FT   VARIANT     515    515       Q -> E (in dbSNP:rs180222).
FT                                /FTId=VAR_016190.
FT   VARIANT     604    604       S -> D (requires 2 nucleotide
FT                                substitutions; dbSNP:rs2069547).
FT                                /FTId=VAR_016852.
FT   VARIANT     653    653       G -> D (in dbSNP:rs2069548).
FT                                /FTId=VAR_016853.
FT   VARIANT     734    734       S -> A (polymorphism associated with
FT                                AITD3; dbSNP:rs180223).
FT                                /FTId=VAR_010213.
FT   VARIANT     777    777       P -> L (in dbSNP:rs3739274).
FT                                /FTId=VAR_049077.
FT   VARIANT     815    815       G -> R (in dbSNP:rs16904774).
FT                                /FTId=VAR_049078.
FT   VARIANT     830    830       Q -> E (in dbSNP:rs2076737).
FT                                /FTId=VAR_010214.
FT   VARIANT     870    870       Q -> H (in dbSNP:rs2229843).
FT                                /FTId=VAR_002365.
FT   VARIANT     985    985       Missing.
FT                                /FTId=VAR_016854.
FT   VARIANT     988    988       R -> P (in dbSNP:rs16893332).
FT                                /FTId=VAR_049079.
FT   VARIANT    1028   1028       M -> V (polymorphism associated with
FT                                AITD3; dbSNP:rs853326).
FT                                /FTId=VAR_010215.
FT   VARIANT    1043   1043       H -> Y.
FT                                /FTId=VAR_016855.
FT   VARIANT    1059   1059       I -> T.
FT                                /FTId=VAR_016856.
FT   VARIANT    1063   1063       L -> M (in dbSNP:rs11992497).
FT                                /FTId=VAR_049080.
FT   VARIANT    1222   1222       S -> L (in dbSNP:rs12549018).
FT                                /FTId=VAR_049081.
FT   VARIANT    1264   1264       C -> R (in TDH3; autosomal recessive;
FT                                dbSNP:rs2076738).
FT                                /FTId=VAR_010216.
FT   VARIANT    1312   1312       D -> G (in dbSNP:rs2069556).
FT                                /FTId=VAR_010217.
FT   VARIANT    1437   1437       W -> R (in dbSNP:rs2069558).
FT                                /FTId=VAR_016857.
FT   VARIANT    1463   1463       P -> H.
FT                                /FTId=VAR_016858.
FT   VARIANT    1740   1740       T -> K (in dbSNP:rs16904791).
FT                                /FTId=VAR_049082.
FT   VARIANT    1838   1838       D -> N (in dbSNP:rs2069561).
FT                                /FTId=VAR_010218.
FT   VARIANT    1897   1897       C -> Y (in TDH3).
FT                                /FTId=VAR_063035.
FT   VARIANT    1936   1936       A -> T (in dbSNP:rs2069562).
FT                                /FTId=VAR_016859.
FT   VARIANT    1974   1974       M -> T (in dbSNP:rs56230101).
FT                                /FTId=VAR_061173.
FT   VARIANT    1979   1979       R -> W (polymorphism associated with
FT                                AITD3).
FT                                /FTId=VAR_032013.
FT   VARIANT    1996   1996       C -> S (in TDH3; autosomal recessive;
FT                                dbSNP:rs2076739).
FT                                /FTId=VAR_010219.
FT   VARIANT    1999   1999       R -> W (in dbSNP:rs2076740).
FT                                /FTId=VAR_010220.
FT   VARIANT    2091   2091       D -> E.
FT                                /FTId=VAR_016860.
FT   VARIANT    2149   2149       P -> L (in dbSNP:rs2069564).
FT                                /FTId=VAR_016861.
FT   VARIANT    2170   2170       Q -> R (in dbSNP:rs2069565).
FT                                /FTId=VAR_016862.
FT   VARIANT    2234   2234       A -> D (in TDH3; reduces thyroglobulin
FT                                synthesis and secretion; promotes
FT                                thyroglobulin retention within the
FT                                endoplasmic reticulum).
FT                                /FTId=VAR_063036.
FT   VARIANT    2242   2242       R -> H (in dbSNP:rs2069566).
FT                                /FTId=VAR_016863.
FT   VARIANT    2336   2336       R -> Q (in TDH3).
FT                                /FTId=VAR_063037.
FT   VARIANT    2375   2375       G -> R (in TDH3).
FT                                /FTId=VAR_063038.
FT   VARIANT    2455   2455       R -> H (in dbSNP:rs2272707).
FT                                /FTId=VAR_049083.
FT   VARIANT    2469   2469       L -> P (in dbSNP:rs2069568).
FT                                /FTId=VAR_049084.
FT   VARIANT    2501   2501       W -> R (in dbSNP:rs2069569).
FT                                /FTId=VAR_010221.
FT   VARIANT    2526   2526       F -> L (in dbSNP:rs12114109).
FT                                /FTId=VAR_049085.
FT   VARIANT    2530   2530       R -> Q (in dbSNP:rs1133076).
FT                                /FTId=VAR_010222.
FT   VARIANT    2616   2616       N -> S (in dbSNP:rs10091530).
FT                                /FTId=VAR_049086.
FT   CONFLICT     23     25       EYQ -> GKF (in Ref. 6; CAA26527).
FT   CONFLICT    848    848       Missing (in Ref. 13; AA sequence).
FT   CONFLICT    984    985       EQ -> DR (in Ref. 5; CAA29456).
FT   CONFLICT   1359   1360       Missing (in Ref. 13; AA sequence).
FT   CONFLICT   1717   1717       L -> A (in Ref. 13; AA sequence).
FT   CONFLICT   1776   1776       T -> S (in Ref. 13; AA sequence).
FT   CONFLICT   2019   2019       G -> H (in Ref. 13; AA sequence).
FT   CONFLICT   2287   2287       F -> P (in Ref. 13; AA sequence).
SQ   SEQUENCE   2768 AA;  304790 MW;  69A87D935F1BAA72 CRC64;
     MALVLEIFTL LASICWVSAN IFEYQVDAQP LRPCELQRET AFLKQADYVP QCAEDGSFQT
     VQCQNDGRSC WCVGANGSEV LGSRQPGRPV ACLSFCQLQK QQILLSGYIN STDTSYLPQC
     QDSGDYAPVQ CDVQQVQCWC VDAEGMEVYG TRQLGRPKRC PRSCEIRNRR LLHGVGDKSP
     PQCSAEGEFM PVQCKFVNTT DMMIFDLVHS YNRFPDAFVT FSSFQRRFPE VSGYCHCADS
     QGRELAETGL ELLLDEIYDT IFAGLDLPST FTETTLYRIL QRRFLAVQSV ISGRFRCPTK
     CEVERFTATS FGHPYVPSCR RNGDYQAVQC QTEGPCWCVD AQGKEMHGTR QQGEPPSCAE
     GQSCASERQQ ALSRLYFGTS GYFSQHDLFS SPEKRWASPR VARFATSCPP TIKELFVDSG
     LLRPMVEGQS QQFSVSENLL KEAIRAIFPS RGLARLALQF TTNPKRLQQN LFGGKFLVNV
     GQFNLSGALG TRGTFNFSQF FQQLGLASFL NGGRQEDLAK PLSVGLDSNS STGTPEAAKK
     DGTMNKPTVG SFGFEINLQE NQNALKFLAS LLELPEFLLF LQHAISVPED VARDLGDVME
     TVLSSQTCEQ TPERLFVPSC TTEGSYEDVQ CFSGECWCVN SWGKELPGSR VRGGQPRCPT
     DCEKQRARMQ SLMGSQPAGS TLFVPACTSE GHFLPVQCFN SECYCVDAEG QAIPGTRSAI
     GKPKKCPTPC QLQSEQAFLR TVQALLSNSS MLPTLSDTYI PQCSTDGQWR QVQCNGPPEQ
     VFELYQRWEA QNKGQDLTPA KLLVKIMSYR EAASGNFSLF IQSLYEAGQQ DVFPVLSQYP
     SLQDVPLAAL EGKRPQPREN ILLEPYLFWQ ILNGQLSQYP GSYSDFSTPL AHFDLRNCWC
     VDEAGQELEG MRSEPSKLPT CPGSCEEAKL RVLQFIRETE EIVSASNSSR FPLGESFLVA
     KGIRLRNEDL GLPPLFPPRE AFAEQFLRGS DYAIRLAAQS TLSFYQRRRF SPDDSAGASA
     LLRSGPYMPQ CDAFGSWEPV QCHAGTGHCW CVDEKGGFIP GSLTARSLQI PQCPTTCEKS
     RTSGLLSSWK QARSQENPSP KDLFVPACLE TGEYARLQAS GAGTWCVDPA SGEELRPGSS
     SSAQCPSLCN VLKSGVLSRR VSPGYVPACR AEDGGFSPVQ CDQAQGSCWC VMDSGEEVPG
     TRVTGGQPAC ESPRCPLPFN ASEVVGGTIL CETISGPTGS AMQQCQLLCR QGSWSVFPPG
     PLICSLESGR WESQLPQPRA CQRPQLWQTI QTQGHFQLQL PPGKMCSADY ADLLQTFQVF
     ILDELTARGF CQIQVKTFGT LVSIPVCNNS SVQVGCLTRE RLGVNVTWKS RLEDIPVASL
     PDLHDIERAL VGKDLLGRFT DLIQSGSFQL HLDSKTFPAE TIRFLQGDHF GTSPRTWFGC
     SEGFYQVLTS EASQDGLGCV KCPEGSYSQD EECIPCPVGF YQEQAGSLAC VPCPVGRTTI
     SAGAFSQTHC VTDCQRNEAG LQCDQNGQYR ASQKDRGSGK AFCVDGEGRR LPWWETEAPL
     EDSQCLMMQK FEKVPESKVI FDANAPVAVR SKVPDSEFPV MQCLTDCTED EACSFFTVST
     TEPEISCDFY AWTSDNVACM TSDQKRDALG NSKATSFGSL RCQVKVRSHG QDSPAVYLKK
     GQGSTTTLQK RFEPTGFQNM LSGLYNPIVF SASGANLTDA HLFCLLACDR DLCCDGFVLT
     QVQGGAIICG LLSSPSVLLC NVKDWMDPSE AWANATCPGV TYDQESHQVI LRLGDQEFIK
     SLTPLEGTQD TFTNFQQVYL WKDSDMGSRP ESMGCRKDTV PRPASPTEAG LTTELFSPVD
     LNQVIVNGNQ SLSSQKHWLF KHLFSAQQAN LWCLSRCVQE HSFCQLAEIT ESASLYFTCT
     LYPEAQVCDD IMESNAQGCR LILPQMPKAL FRKKVILEDK VKNFYTRLPF QKLMGISIRN
     KVPMSEKSIS NGFFECERRC DADPCCTGFG FLNVSQLKGG EVTCLTLNSL GIQMCSEENG
     GAWRILDCGS PDIEVHTYPF GWYQKPIAQN NAPSFCPLVV LPSLTEKVSL DSWQSLALSS
     VVVDPSIRHF DVAHVSTAAT SNFSAVRDLC LSECSQHEAC LITTLQTQPG AVRCMFYADT
     QSCTHSLQGQ NCRLLLREEA THIYRKPGIS LLSYEASVPS VPISTHGRLL GRSQAIQVGT
     SWKQVDQFLG VPYAAPPLAE RRFQAPEPLN WTGSWDASKP RASCWQPGTR TSTSPGVSED
     CLYLNVFIPQ NVAPNASVLV FFHNTMDREE SEGWPAIDGS FLAAVGNLIV VTASYRVGVF
     GFLSSGSGEV SGNWGLLDQV AALTWVQTHI RGFGGDPRRV SLAADRGGAD VASIHLLTAR
     ATNSQLFRRA VLMGGSALSP AAVISHERAQ QQAIALAKEV SCPMSSSQEV VSCLRQKPAN
     VLNDAQTKLL AVSGPFHYWG PVIDGHFLRE PPARALKRSL WVEVDLLIGS SQDDGLINRA
     KAVKQFEESR GRTSSKTAFY QALQNSLGGE DSDARVEAAA TWYYSLEHST DDYASFSRAL
     ENATRDYFII CPIIDMASAW AKRARGNVFM YHAPENYGHG SLELLADVQF ALGLPFYPAY
     EGQFSLEEKS LSLKIMQYFS HFIRSGNPNY PYEFSRKVPT FATPWPDFVP RAGGENYKEF
     SELLPNRQGL KKADCSFWSK YISSLKTSAD GAKGGQSAES EEEELTAGSG LREDLLSLQE
     PGSKTYSK
//
